BLFE OTC
BioLife Sciences Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$884K
-5201911.8% ▼
Capital Expenditures
$961
+0.0% ▲
Free Cash Flow
-$885K
-5207564.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$35K
+2764.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$19K | -$340K | -$53K | -$1K | -$1M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $8K | $22K | $25K | $1K | $379K |
| Other Non-Cash Items | -$8K | $300K | -$10K | $0 | $4K |
| Operating Cash Flow | -$12K | -$19K | -$13K | $17 | -$884K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$961 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | -$961 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $876K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $12K | $31K | $2K | $0 | $0 |
| Financing Cash Flow | $12K | $31K | $2K | $0 | $876K |
| Net Change in Cash | $0 | $12K | -$11K | -$1K | $35K |
| Cash End of Period | $0 | $12K | $1K | $17 | $35K |
| Free Cash Flow | -$12K | -$19K | -$13K | $17 | -$885K |